We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Manufacturers of all in vitro diagnostics now have until June 30, 2015, to file an application for inclusion of currently marketed products on the Australia Register of Therapeutic Goods. The original deadline was June 30 of this year. Read More
South Africa is taking another stab at regulating medical devices and in vitro diagnostic products, this time via a regulation that would bring them under the purview of the Medicines Control Council. Read More
Enhancement Medical received a warning letter for failing to document supplier evaluations related to production of the Expression intranasal splint. Read More
The FDA has granted RevMedx’s request to move nonabsorbable expandable hemostatic sponges to Class II, but is requiring special controls to ensure the device is effective when used. Read More
Rumors of a Medtronic/Covidien merger were confirmed last week with the announcement that Medtronic will pay $42.9 billion in cash and stock for the Dublin-based devicemaker. Read More
CDRH is expecting a large number of devicemakers to take advantage of the Expedited Access PMA program proposed in draft guidance in April, center Director Jeffrey Shuren said during a Thursday webinar hosted by the Pew Charitable Trusts. Read More
Prices for medical technologies grew on average just 1 percent per year over the past two decades, noticeably slower than other U.S. costs, new AdvaMed research shows. Read More
Medtech companies are under no obligation to correct misleading third-party statements or claims about their products made on social media, websites and online forums — even if the website is owned by the manufacturer. Read More